1034 Results

People

  1. Norton
    Norton
  2. Saltz
    Saltz
  3. Motzer
    Motzer
  4. Kris
    Kris
  5. Hudis
    Hudis
  6. Seidman
    Seidman
  7. Brennan
    Brennan
  8. Panageas
    Panageas
  9. Gonen
    Gonen
  10. Scher
    Scher

Groups

  1. Department of Medicine (482)
  2. Solid Tumor Oncology Division (363)
  3. Surgery (208)
  4. Epidemiology and Biostatistics (169)
  5. Survivorship Research (164)
  6. Biostatistics Service (123)
  7. Population Sciences Research Program (119)
  8. Hematologic Malignancies, Division of (109)
  9. Sloan Kettering Institute Faculty (103)
  10. Center for Hematologic Malignancies (96)
  1. "controlled clinical trial"
Formats
  1. Journal Article (1008)
  2. Conference Paper (22)
  3. Book Section (1)
  4. Meeting Abstract (1)
  5. Research Letter (1)
  6. Review (1)
Groups
  1. Department of Medicine (482)
  2. Solid Tumor Oncology Division (363)
  3. Surgery (208)
  4. Epidemiology and Biostatistics (169)
  5. Survivorship Research (164)
  6. Biostatistics Service (123)

More Groups

People
  1. Larry Norton (41)
  2. Leonard Saltz (37)
  3. Robert Motzer (35)
  4. Mark Kris (33)
  5. Nancy Kemeny (32)
  6. Clifford Hudis (31)

More People

Years
  1. 2025 (5)
  2. 2024 (8)
  3. 2023 (5)
  4. 2022 (9)
  5. 2021 (3)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (140)
  2. Clinical Cancer Research (56)
  3. Cancer (46)
  4. New England Journal of Medicine (28)
  5. International Journal of Radiation Oncology, Biology, Physics (25)
  6. Surgical Oncology Clinics of North America (22)

More Publications

Publishers
  1. Elsevier Inc. (153)
  2. American Society of Clinical Oncology (142)
  3. Springer (89)
  4. American Association for Cancer Research (70)
  5. Wiley Blackwell (65)
  6. Lippincott Williams & Wilkins (60)

More Publishers

Results (1034)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cosmetic outcomes following breast-conservation surgery and radiation for multiple ipsilateral breast cancer: Data from the alliance Z11102 study
    Journal Article

    Rosenkranz, K. M.; Ballman, K.; McCall, L.; McCarthy, C.; Kubicky, C. D.; Cuttino, L.; Hunt, K. K.; Giuliano, A.; Van Zee, K. J.; Haffty, B.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma
    Journal Article

    Fowler, N. H.; Nastoupil, L.; De Vos, S.; Knapp, M.; Flinn, I. W.; Chen, R.; Advani, R. H.; Bhatia, S.; Martin, P.; Mena, R.; more...
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma
    Journal Article

    Noel, M.; O’Reilly, E. M.; Wolpin, B. M.; Ryan, D. P.; Bullock, A. J.; Britten, C. D.; Linehan, D. C.; Belt, B. A.; Gamelin, E. C.; Ganguly, B.; more...
    Investigational New Drugs (2020)

    Fulltext@MSK | Save
  • Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma
    Journal Article

    Gluck, W. L.; Gounder, M. M.; Frank, R.; Eskens, F.; Blay, J. Y.; Cassier, P. A.; Soria, J. C.; Chawla, S.; de Weger, V.; Wagner, A. J.; more...
    Investigational New Drugs (2020)

    Fulltext@MSK | Save
  • Safety of human adipose stromal vascular fraction cells isolated with a closed system device in an immunocompetent murine pressure ulcer model
    Journal Article

    Bukowska, J.; Alarcon Uquillas, A.; Wu, X.; Frazier, T.; Walendzik, K.; Vanek, M.; Gaupp, D.; Bunnell, B. A.; Kosnik, P.; Mehrara, B.; more...
    Stem Cells and Development (2020)

    Fulltext@MSK | Save
  • Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)
    Journal Article

    Ryan, C. J.; Dutta, S.; Kelly, W. K.; Russell, C.; Small, E. J.; Morris, M. J.; Taplin, M. E.; Halabi, S.; From The Alliance for Clinical Trials in Oncology Genitourinary Committee
    Prostate Cancer and Prostatic Diseases (2020)

    Fulltext@MSK | Save
  • TATTON: A multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
    Journal Article

    Oxnard, G. R.; Yang, J. C. H.; Yu, H.; Kim, S. W.; Saka, H.; Horn, L.; Goto, K.; Ohe, Y.; Mann, H.; Thress, K. S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Associations between intraoperative factors and surgeons’ self-assessed operative satisfaction
    Journal Article

    Erestam, S.; Bock, D.; Andersson, A. E.; Bjartell, A.; Carlsson, S.; Kollberg, K. S.; Sjoberg, D.; Steineck, G.; Stranne, J.; Thorsteinsdottir, T.; more...
    Surgical Endoscopy (2020)

    Fulltext@MSK | Save
  • Combined PIK3CA and FGFR inhibition with alpelisib and infigratinib in patients with PIK3CA-mutant solid tumors, with or without FGFR alterations
    Journal Article

    Hyman, D. M.; Tran, B.; Paz-Ares, L.; Machiels, J. P.; Schellens, J. H.; Bedard, P. L.; Campone, M.; Cassier, P. A.; Sarantopoulos, J.; Vaishampayan, U.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer
    Journal Article

    Higano, C. S.; Armstrong, A. J.; Sartor, A. O.; Vogelzang, N. J.; Kantoff, P. W.; McLeod, D. G.; Pieczonka, C. M.; Penson, D. F.; Shore, N. D.; Vacirca, J.; more...
    Cancer (2019)

    Fulltext@MSK | Save